NCT03417986
Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 24, 2017
Completion: Oct 22, 2021